A Business Development View of the Immunology Landscape
In this Pullan’s Pieces webinar, the third in the series, business development consultant, Linda Pullan, PhD, presented an overview of the immunology therapeutics landscape. This included snapshots of diseases, unmet needs, sales of top drugs and forecasts, drugs in development, top molecular targets, venture and licensing deals.
What you’ll learn:
- Where is inflammation drug development focused?
- What are the popular targets?
- Where are the big sales and what is the forecast?
- Who have been active dealmakers?
- What’s to come in the next few years.
Sign up to hear this, plus a wide-range examination of the immunology therapeutics landscape including clarity and perspective on the complexities and nuances.
